Amid the worst U.S.-China trade clash in modern history, Michelle Xia thinks she has something Chinese that Americans will want. It isn’t a $3 T-shirt or an electronic gadget. It is a cancer ...

Laurus Labs advanced by 4.8 per cent, while Aurobindo Pharma rose 4.9 per cent. Nifty Pharma has fallen by 12.8 per cent so far this year, with Natco Pharma and Granules India leading the plunge.

("South Rampart" or the "Company"), a clinical-stage biotechnology company advancing best-in-class, non-opioid pain therapeutics, today announced the appointment of Pete November, CEO of Ochsner ...

The founder and former CEO of Spokane pharmaceutical manufacturing startup Selkirk Pharma Inc. claims in corporate and legal filings that he was ousted from the company’s C-suite and board of ...

As CEO of Ochsner Health ... and a global economic impact of approximately $9.6 trillion. About South Rampart Pharma, Inc. South Rampart Pharma, Inc. is a clinical-stage life science biotechnology ...

In India, it is the pharma sector that fits the bill. For a simple reason. While the Trump regime will make noises about tariffs on Indian pharma imports, the reality is that, given the poor state of ...

Shopify CEO wants workers to prove they need people rather than AI AI will also play a role in employee evaluation, review processes Qualaix CEO tells NewsNation the move is a great motivator for ...

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px&apos ...

The drug modifies SMN2 gene splicing, improving motor neuron functionality. The plaintiffs, Roche, alleged that NATCO Pharma infringed their patent by initiating production of Risdiplam API (Active ...

After another solid year that included 12% growth in the top line, Vertex has bumped up its compensation for CEO Reshma Kewalramani, M.D., to $21.5 million, according to the company’s proxy filing.

Drugmaker Natco Pharma on Tuesday said it intends to launch its generic version of spinal muscular atrophy drug Risdiplam only after and subject to successful clarity from the Appellate Bench of ...